Javascript är avstängt eller blockerat i din webbläsare. Detta kan leda till att vissa delar av vår webbplats inte fungerar som de ska. Sätt på javascript för optimal funktionalitet och utseende.

Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Kontakt

EpiHealth Styrelse

Sölve Elmståhl ler mot kameran och står bredvid ett konferensbord.Foto

Koordinator

Sölve Elmståhl 
Professor i geriatrik, LU, samt ansvarig för EpiHealths screeningkohort
Tel +46 40 39 13 20
Solve [dot] Elmstahl [at] med [dot] lu [dot] se 

 

Sölve Elmståhl

Sölve Elmståhl is a Professor of Geriatric Medicine and leader of the research group at the Division of Geriatric Medicine. Main focus are research on epidemiological perspective on ageing and functioning, especially vascular risk factors and cognition and osteoporosis. He is the PI of the ongoing longitudinal cohort study Good Ageing in SKåne (GÅS) part of Swedish National study on Ageing and Care (SNAC) and the cohort study "Men born 1914", and since 2009 coordinating the EpiHealth cohort study in Skåne. Sölves profil i Lunds universitets forskningsportal

 

 

Marju Orho-Melander.Foto

Vice koordinator

Marju Orho-Melander 
Professor i Diabetes och kardiovaskulär sjukdom - genetisk epidemiologi, LU
Tel + 46 40 39 12 10
Marju [dot] Orho-Melander [at] med [dot] lu [dot] se 

Marju Orho-Melander

Marju Orho-Melander is professor of genetic epidemiology at the Department of Clinical Sciences at Lund University. Her current main research interests are related to prediction and prevention of cardiometabolic diseases with main focus in genetic and circulating biomarkers, diet, gut microbiota and causal risk factors. Orho-Melander has published >240 papers in international peer reviewed scientific journals and these have been cited >20,000 times (h-index 64).  She has received several prestigious prizes and grants as the Fernström Prize for younger investigator at Lund University 2010, the Distinguished Younger Researcher Grant by the Swedish Research Council 2013-2018 and an ERC-Consolidator grant 2015-2020. Marjus profil i Lunds universitets forskningsportal

LUNDS UNIVERSITET

Kajsa Brolin

Studeranderespresentant

Kajsa Brolin
Doktorand
Tel +46 46 222 06 35
kajsa [dot] brolin [at] med [dot] lu [dot] se

Kajsa Brolin

Kajsa Brolin is a PhD student in the research group Translational Neurogenetics led by Maria Swanberg. Kajsa has a Bachelor of Medical Science in Biomedicine and a Master of Science in Molecular Biology from Lund University and is a licensed pharmacist after completing a Bachelor of Science in Pharmacy from Linnaeus University. Her PhD project is focused on epidemiology and genetics in Parkinson’s disease etiology, primarily in the Multipark biobank sample collection (MPBC). The PhD project enables her to utilize her acquired knowledge within the various fields of medical science and develop her skills as an independent researcher within the field of genetics and epidemiology. Kajsas profil i Lunds universitets forskningsportal

Jonas Björk.Foto

Styrelsemedlem

Jonas Björk
Professor vid Inst för laboratoriemedicin och Centrum för ekonomisk demografi, LU
Tel +46 46 222 69 16
jonas [dot] bjork [at] med [dot] lu [dot] se 

Jonas Björk

Jonas Björk är nyutnämnd professor i epidemiologi med inriktning mot epidemiologisk metodik vid institutionen för laboratoriemedicin i Lund. Jonas forskning spänner över så skilda fält som metoder för skattning av njurfunktion, riskmodellering inom klinisk epidemiologi, närmiljöns betydelse för hälsa och välmående samt mer teoretiska frågeställningar inom epidemiologisk metodik. Jonas är för närvarande assisterande koordinator för forskarnätverket SIMSAM EarlyLife (www.med.lu.se/simsam_early_life)  vid Lunds universitet, medlem av styrelsen för svensk epidemiologisk förening och koordinerar verksamheten inom medicinsk statistik och epidemiologi vid FoU-centrum Skåne (www.skane.se/mse). Jonas profil i Lunds universitets forskningsportal

Martin Englund.Havet synns i bakgrunden.Foto

Styrelsemedlem

Martin Englund, MD, PhD
Clinical Epidemiology Unit, Orthopedics, Department of Clinical Sicences, Lund University
Tel: +46 46 17 13 94
martin [dot] englund [at] med [dot] lu [dot] se

Martin Englund

Martin Englund is an epidemiologist and clinical investigator. He completed his MD in 1998, and received his PhD in Orthopedics in 2004. He did a two-year postdoctoral training at Boston University, United States, where he also earned his MSc degree in Epidemiology. Dr. Englund heads the Clinical Epidemiology Unit, Orthopedics, which is a cross-disciplinary research group at Lund University. Englund focuses on osteoarthritis research, including preclinical experiments as well as clinical studies and epidemiological research suing population-based register data. His main research focus is the role of meniscus in early knee osteoarthritis development as well as the societal burden of musculoskeletal disease. Martins profil i Lunds universitets forskningsportal

Karin Källén.Foto

Styrelsemedlem

Karin Källén
Professor i reproduktionsepidemiologi vid Lunds universitet
Tel: +46 (0)46 17 72 94
Karin [dot] Kallen [at] med [dot] lu [dot] se

Karin Källén

Karin Källén is an associate professor of reproduction epidemiology at the University of Lund, and is also a part-time employee at the Swedish National Board of Health and Welfare (Socialstyrelsen), department of statistics, monitoring and evaluation. The main research areas are maternal drugs during pregnancy and risk for congenital birth defects, risk factors and other aspects of extreme prematurity, and obstetrical interventions in relation to pregnancy outcomes – both perinatal- and long term outcomes. Karin Källén is the data manager of one regional register for quality assessment (Perinatal Reviation South), the data manger of the quality register regarding all in vitro fertilizations in Sweden (Q-IVF), member of the steering committees of two national quality registries for perinatal care (PNQn and PNQo, respectively), and is the main epidemiologist and member of the steering group of the EXPRESS-study group (a national study on extreme prematurity involving merely all Swedish obstetriscians and neonatologists). Furthermore, Karin Källén is responsible for the national surveillance of congenital malformations performed by the National Board of Health and Welfare, and is the Swedish contact person for two international associations for epidemiological research on congenital birth defects (EUROCAT and Clearinghouse for congenital malformations, respectively). Karins profil i Lunds universitets forskningsportal

Charlotte Ling.Foto

Styrelsemedlem

Charlotte Ling
Professor i endokrinologi, forskargruppschef diabetes - epigenetik vid Inst. för kliniska vetenskaper, LU
charlotte [dot] ling [at] med [dot] lu [dot] se

Charlotte Ling

Charlotte Ling is a Professor at Lund University and a principle investigator of the Epigenetics and Diabetes Unit at Lund University Diabetes Centre (LUDC), Sweden. She obtained her PhD in Endocrinology at University of Gothenburg, Sweden in 2002. After a postdoc at Lund University, where she studied genetics of type 2 diabetes, she dedicated her research to the study of epigenetic mechanisms causing type 2 diabetes and metabolic disease. Her research group has pioneered the field of epigenetics in type 2 diabetes. They have made several groundbreaking discoveries such as genome-wide epigenetic modifications in pancreatic islets, skeletal muscle, adipose tissue and the liver from patients with type 2 diabetes compared with non-diabetic control subjects. Dr. Ling’s research group has also shown that genetic and non-genetic factors such as SNPs, exercise, diet, obesity and age alter the genome-wide epigenetic pattern in human primary tissues for type 2 diabetes.Dr. Ling is frequently invited to write review papers and book chapters and to give lectures (e.g. ADA, IDF, Keystone and Endocrine Society) on the topic ‘Epigenetics in Type 2 Diabetes’. Dr. Ling has been awarded research grants from numerous national and international foundations including the Swedish Research Council, Novo Nordisk Excellence award, EFSD-Lilly, Söderberg’s foundation and the European Commission (H2020 and ERC). She has published 111 original publications, 18 invited review papers and 8 book chapters since 1999 including papers in Cell Metabolism, Nature Communications, Science Translational Medicine, JCI, PNAS and Diabetes Care. Dr Ling has a H-index of 48 and ~9300 citation. Charlottes profil i Lunds universitets forskningsportal

Åsa Westrin.Foto

Styrelsemedlem

Åsa Westrin
Professor i psykiatri vid Inst. för kliniska vetenskaper, LU
asa [dot] westrin [at] med [dot] lu [dot] se

Åsa Westrin

Åsa Westrin is Professor of psychiatry at the Department of Clinical Sciences, Lund at Lund University. Her research area is within suicide research and includes psychobiological vulnerability and treatment of suicide attempters as well as the health care given to individuals who have died by suicide. She is PI of three major research projects: Genes, Depression, and Suicidality (GEN-DS), Attempted Suicide Short Intervention (ASSIP) in Sweden and Retrospective review of medical records for individuals who died by Suicide in Sweden in 2015. Åsas profil i Lunds universitets forskningsportal

Martin L. Olsson.Foto

Fakultetsledningsrepresentant

Martin L Olsson
Professor, överläkare, Vicedekan för forskningsinfrastruktur
Tel: +46 (0)46 222 32 07
Martin_L [dot] Olsson [at] med [dot] lu [dot] se

Martin L. Olsson

Martin L Olsson är vicedekan med ansvar för medicinska fakultetens forskningsinfrastruktur. Han är också professor och överläkare i transfusionsmedicin vid Institutionen för laboratoriemedicin och forskar om vår vanligaste cell, den röda blodkroppen och dess ytstrukturers betydelse vid transfusion, infektion, blodbildning och blodproppsbildning. För sin forskning utsågs han till Wallenberg Clinical Scholar 2016-2020 och sitter under perioden 2016-2022 i styrelsen för International Society of Blood Transfusion (ISBT), f.n. i rollen som President. Martins profil i Lunds universitets forskningsportal

UPPSALA UNIVERSITET

Tove Fall sitter på en soffa och ler.Foto

Styrelsemedlem

Tove Fall
Docent i epidemiologi vid Uppsala Universitet.
tove [dot] fall [at] medsci [dot] uu [dot] se

Tove Fall

Tove Fall forskar om både molekylära biomarkörer och livsstilsfaktorer med betydelse för utveckling av diabetes och hjärtkärlsjukdom. Hon kombinerar information från olika register med mätningar gjorda i stora befolkningsstudier. Ett av hennes mer uppmärksammade projekt handlar om hundens påverkan på ägarens hälsa. Tove Fall är mottagare av ett Starting Grant från Europeiska Forskningsrådet, ERC och är ledamot i Sveriges Unga Akademi.

Lars Lind sitter vid en skärm och ler.Foto

Styrelsemedlem

Lars Lind 
Professor vid Inst för medicinska vetenskaper, UU
Tel +46 (0)730 50 28 78
lars [dot] lind [at] medsci [dot] uu [dot] se 

Lars Lind

Lars Lind, Professor of Medicine at Uppsala University. Research area is cardiovascular epidemiology. Currently working with the ULSAM, PIVUS (www.medsci.uu.se/pivus/pivus.htm) and POEM cohorts. Initiator of the EpiHealth cohort study (www.epihealth.se). Tutor for 24 PhD students and has published >350 research papers.

Karl Michaelsson sitter vid ett bord och ler.Pärmar synns i bakgrunden.Foto

Styrelsemedlem

Karl Michaelsson 
Professor at the Department of Surgical Services at Uppsala University
Tel +46 18-611 95 45
karl [dot] michaelsson [at] surgsci [dot] uu [dot] se 

Karl Michaelsson

Karl Michaelsson professor in Medical Epidemiology and Senior Consultant in Orthopaedics at Department of Surgical Sciences at Uppsala University. Presently, I have a senior research position funded from the Swedish Research Council (VR) with workplace at Uppsala Clinical Research Center (www.ucr.uu.se). My main research interest is osteoporotic fractures but I also investigate other musculoskeletal disorders and mortality as outcomes. I have performed studies on diet, vitamins, physical activity and genes with case-control and cohort analysis, including time-dependent exposures and different twin designs. Involved in building Lifegene (headed the musculo-skeletal research group and member of Lifegene’s Executive committee), responsible for an epidemiology network in Uppsala (http://www.ucr.uu.se/epinet ) and a national osteoporosis network (http://www.ucr.uu.se/osteoporosnet ).

Johan Sundström står i en läkarrock och håller ett "hjärta" i handen.Foto

Styrelsemedlem

Johan Sundström
Docent vid Inst för medicinska vetenskaper, Akademiska sjukhuset i Uppsala.
Mobil +46 (0)70-422 52 20
Tel +46 (0)18-611 98 89
johan [dot] sundstrom [at] medsci [dot] uu [dot] se

Johan Sundström

Johan Sundström is an associate professor of cardiovascular epidemiology, focusing on researching hypertension-related disease in longitudinal study designs. After completion of his PhD thesis in 2001, he was a research fellow at the Framingham Heart Study in 2002-2003. He currently leads a research group with a handful of PhD and MD students, and is a course leader for methodological courses compulsory for all PhD students of Uppsala University Medical Faculty, as well as co-course leader for an epidemiology course for PhD students. In addition to his engagement in EpiHealth, he is the coordinator of the cardiovascular research group in BBMRI.SE and national coordinator for a large clinical trial in hypertension, APOLLO. In addition to his research activities, he works half-time as a physician. Initiator of the Epihealth project Metahealth, a research infrastructure for individual participant data meta-analysis of cohort studies, aimed at studying risk factors for uncommon diseases.